Seeing with new eyes: finding a path to early intervention trials in Alzheimer's disease.
Cedarbaum
J M
JM
Elan Pharmaceuticals, Inc., South San Francisco, CA 94080, USA. jesse.cedarbaum@elan.com
Crans
G
G
Grundman
M
M
D000465:Algorithms; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000188:drug therapy; D015415:Biomarkers / Q000032:analysis; D002986:Clinical Trials as Topic / Q000379:methods*; D003072:Cognition Disorders / Q000175:diagnosis; D018450:Disease Progression; D006801:Humans; D018579:Patient Selection; D012720:Severity of Illness Index; D016896:Treatment Outcome
D015415:Biomarkers